Primary sclerosing cholangitis
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by
intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and …
intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and …
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
K Khalaf, P Tornese, A Cocco, A Albanese - Translational …, 2022 - Springer
Most neurodegenerative disorders are diseases of protein homeostasis, with misfolded
aggregates accumulating. The neurodegenerative process is mediated by numerous …
aggregates accumulating. The neurodegenerative process is mediated by numerous …
EASL Clinical Practice Guidelines on sclerosing cholangitis
O Chazouilleres, U Beuers, A Bergquist, TH Karlsen… - Journal of …, 2022 - Elsevier
Management of primary or secondary sclerosing cholangitis is challenging. These Clinical
Practice Guidelines have been developed to provide practical guidance on debated topics …
Practice Guidelines have been developed to provide practical guidance on debated topics …
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis
Background & Aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary
disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of …
disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of …
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
MH Chapman, D Thorburn, GM Hirschfield… - Gut, 2019 - gut.bmj.com
These guidelines on the management of primary sclerosing cholangitis (PSC) were
commissioned by the British Society of Gastroenterology liver section. The guideline writing …
commissioned by the British Society of Gastroenterology liver section. The guideline writing …
ACG clinical guideline: primary sclerosing cholangitis
KD Lindor, KV Kowdley… - Official journal of the …, 2015 - journals.lww.com
Primary sclerosing cholangitis is a chronic cholestatic liver disease that can shorten life and
may require liver transplantation. The cause is unknown, although it is commonly associated …
may require liver transplantation. The cause is unknown, although it is commonly associated …
[PDF][PDF] The nonsteroidal farnesoid X receptor agonist cilofexor (GS‐9674) improves markers of cholestasis and liver injury in patients with primary sclerosing …
M Trauner, A Gulamhusein, B Hameed… - …, 2019 - Wiley Online Library
Primary sclerosing cholangitis (PSC) represents a major unmet medical need. In a phase II
double‐blind, placebo‐controlled study, we tested the safety and efficacy of cilofexor …
double‐blind, placebo‐controlled study, we tested the safety and efficacy of cilofexor …
Evidence-based clinical practice guidelines for liver cirrhosis 2015
H Fukui, H Saito, Y Ueno, H Uto, K Obara… - Journal of …, 2016 - Springer
Abstract The Japanese Society of Gastroenterology revised the evidence-based clinical
practice guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected …
practice guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected …
[PDF][PDF] Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
K Boonstra, RK Weersma, KJ van Erpecum… - …, 2013 - Wiley Online Library
Extensive population‐based studies are much needed to accurately establish epidemiology
and disease course in patients with primary sclerosing cholangitis (PSC). We aimed to …
and disease course in patients with primary sclerosing cholangitis (PSC). We aimed to …